132 related articles for article (PubMed ID: 3931537)
1. Combination of insulin and glibenclamide in the treatment of elderly non-insulin dependent (type 2) diabetic patients.
Kyllästinen M; Groop L
Ann Clin Res; 1985; 17(3):100-4. PubMed ID: 3931537
[TBL] [Abstract][Full Text] [Related]
2. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
Rosak C; Haupt E; Walter T; Werner J
Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
[TBL] [Abstract][Full Text] [Related]
3. Effect of glibenclamide in insulin-treated diabetic patients with a residual insulin secretion.
Mauerhoff T; Ketelslegers JM; Lambert AE
Diabete Metab; 1986 Feb; 12(1):34-8. PubMed ID: 3084315
[TBL] [Abstract][Full Text] [Related]
4. [Long-term effect of combination glibenclamide-insulin treatment in the secondary failure of sulfonylurea therapy--results of a one-year double blind study].
Lundershausen R; Orban S; Pissarek D; Panzram G
Wien Klin Wochenschr; 1987 Sep; 99(17):603-8. PubMed ID: 3118579
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of combined treatment with glibenclamide and insulin in secondary sulfonylurea failure. A controlled multicenter double-blind clinical trial].
Bachmann W; Lotz N; Mehnert H; Rosak C; Schöffling K
Dtsch Med Wochenschr; 1988 Apr; 113(16):631-6. PubMed ID: 3129273
[TBL] [Abstract][Full Text] [Related]
6. Effects of a gel forming dietary fiber, guar gum, on the absorption of glibenclamide and metabolic control and serum lipids in patients with non-insulin-dependent (type 2) diabetes.
Uusitupa M; Södervik H; Silvasti M; Karttunen P
Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):153-7. PubMed ID: 2110937
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacodynamics and pharmacokinetics of 2 glibenclamide preparations in type 2 diabetes. Intraindividual double-blind comparison of Euglucon 5 (HB 419) and Euglucon N (HB 420)].
Haupt E; Putschky F; Zoltobrocki M; Schöffling K
Dtsch Med Wochenschr; 1984 Feb; 109(6):210-3. PubMed ID: 6421561
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacological properties of two galenical preparations of glibenclamide, HB419 and HB420, in non insulin-dependent (type 2) diabetes.
Scheen AJ; Jaminet C; Luyckx AS; Lefebvre PJ
Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):70-6. PubMed ID: 3104218
[TBL] [Abstract][Full Text] [Related]
9. In vivo action of glibenclamide in obese subjects with mild type 2 (non-insulin dependent) diabetes.
Hother-Nielsen O; Schmitz O; Andersen PH; Pedersen O; Beck-Nielsen H
Diabetes Res; 1988 Jun; 8(2):63-70. PubMed ID: 3147830
[TBL] [Abstract][Full Text] [Related]
10. Serum C-peptide after 6 months on glibenclamide remains higher than during insulin treatment.
Peacock I; Watts R; Selby C; Tattersall RB
Diabetes Res; 1987 Oct; 6(2):57-9. PubMed ID: 3123115
[TBL] [Abstract][Full Text] [Related]
11. Response of regimens of insulin therapy in type 2 diabetes mellitus subjects with secondary failure.
Zargar AH; Masoodi SR; Laway BA; Wani AI; Bashir MI
J Assoc Physicians India; 2002 May; 50(5):641-6. PubMed ID: 12186116
[TBL] [Abstract][Full Text] [Related]
12. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
Kigawa Y; Oba K; Futami-Suda S; Norose J; Yasuoka H; Suzuki K; Ouchi M; Watanabe K; Suzuki T; Nakano H
Geriatr Gerontol Int; 2008 Sep; 8(3):160-5. PubMed ID: 18821999
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients.
Kumar S; Prange A; Schulze J; Lettis S; Barnett AH
Diabet Med; 1998 Sep; 15(9):772-9. PubMed ID: 9737807
[TBL] [Abstract][Full Text] [Related]
14. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
[TBL] [Abstract][Full Text] [Related]
15. Randomized study of glibenclamide versus traditional Chinese treatment in type 2 diabetic patients. Chinese-French Scientific Committee for the Study of Diabetes.
Vray M; Attali JR
Diabete Metab; 1995 Dec; 21(6):433-9. PubMed ID: 8593925
[TBL] [Abstract][Full Text] [Related]
16. Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes.
Tan MH; Johns D; Strand J; Halse J; Madsbad S; Eriksson JW; Clausen J; Konkoy CS; Herz M;
Diabet Med; 2004 Aug; 21(8):859-66. PubMed ID: 15270789
[TBL] [Abstract][Full Text] [Related]
17. The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus.
Gudat U; Bungert S; Kemmer F; Heinemann L
Diabet Med; 1998 Mar; 15(3):194-8. PubMed ID: 9545119
[TBL] [Abstract][Full Text] [Related]
18. A double-blind comparison of two glibenclamide preparations, HB 419 and HB 420, in maturity-onset (type 2) diabetic patients.
Arnala I; Uusitupa M
Ann Clin Res; 1983; 15 Suppl 37():33-5. PubMed ID: 6433770
[TBL] [Abstract][Full Text] [Related]
19. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
Johnson JL; Wolf SL; Kabadi UM
Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
